Product features

  • High-performance ELISA kits with guaranteed stability and lyophilized conjugates when necessary.
  • G/M presentation allows flexible IgG and IgM testing combinations within a single kit.
  • Direct in-well sample dilution and sorbent treatment when required.
  • Colour-coded, ready-to-use liquid reagents and individual break-apart wells.
  • Suitable for flexible manual or automated processing.
Kit ELISA

PRODUCTS

MEASLES ELISA IgG/IgM

CE
Indirect immunoenzyme assay to test IgG and/or IgM antibodies against measles virus in human serum/plasma.

Analytes: Measles

Reference G/M1001
Pack size 96 tests

MORE RESOURCES

Virus/Bacterias
RELATED VIRUSES/BACTERIA

Related germs and organisms categorized for this product line.

Measles
Flyers
FLYERS

Downloadable PDF materials, brochures, and technical documents.

ELISA Brochure
ELISA Brochure
Immunology Catalogue
Immunology Catalogue
Blog
BLOG

The latest insights, news, and research articles from our scientific team.

H. pylori stool antigen testing: when the test works, but the workflow no longer does
21 September 2026

H. pylori stool antigen testing: when the test works, but the workflow no longer does

Helicobacter pylori stool antigen testing is an established non-invasive approach for detecting active H. pylori infection. Validated monoclonal stool...

Polymicrobial Vaginal Infections: why third-party controls matter in molecular testing
10 August 2026

Polymicrobial Vaginal Infections: why third-party controls matter in molecular testing

Understanding the complexity of vaginal infectionsVaginal infections are among the most frequent reasons for gynecological consultation, but their dia...

Beyond detection: H. pylori testing in today’s laboratory workflow
31 July 2026

Beyond detection: H. pylori testing in today’s laboratory workflow

Helicobacter pylori remains a highly relevant target in gastrointestinal diagnostics. It is a familiar pathogen, but its clinical importance has not d...

Bibliography
BIBLIOGRAPHY

Scientific bibliography and references related to this product.

Domínguez A, Torner N, Barrabeig I, Rovira A, Rius C, Caylà J, et al. Large Outbreak of Measles in a Community with High Vaccination Coverage: Implications for the Vaccination Schedule. Clin Infect Dis. 2008;47:1143-9.
Fiestas Solórzano V, Gonzáles Noriega M, Fiestas F, Cabezudo E, Suárez M, Suárez V. Evaluation of the seroprotection against measles, rubella and hepatitis B in children under 5 years of age in Peru, 2011. Rev Peru Med Exp Salud Publica. 2012;29(4):437–43
Ghafoori F, Mokhtari-Azad T, Foroushani AR, Farahmand M, Shadab A, Salimi V. Assessing seropositivity of MMR antibodies in individuals aged 2–22: evaluating routine vaccination effectiveness after the 2003 mass campaign—a study from Iran’s National Measle
Guerrero-Fernández MM, Serrano-Álvarez C, Foronda-Bengoa J, Barrero-Hernández FJ, Sorlózano-Puerto A. Intrathecal synthesis of Epstein-Barr virus antibodies 15 years before onset of multiple sclerosis. Mult Scler. 2026 Apr;32(4):444-447
Rahmanian E, Mogharab F, Mogharab V. A Review of Anti-Measles and Anti-Rubella Antibodies in 15 - 25 Year Old Women in Jahrom City In 2011. World Family Medicine Journal/Middle East Journal of Family Medicine. 2017 Nov;15(9):128–34.
See more